FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282965626> ?p ?o ?g. }

• W4282965626 endingPage "1913" @default.
• W4282965626 startingPage "1913" @default.
• W4282965626 abstract "Abstract Background: The National Cancer Institute's Patient-Derived Models Repository (NCI PDMR; pdmr.cancer.gov) is developing a variety of patient-derived xenograft (PDX) models for pre-clinical drug studies. All NCI PDMR models undergo quality control (QC) processes. Two unique QC challenges are: a) to assess genomic stability across PDX model passages; and b) to confirm the suitability of PDX-derived cancer associated fibroblasts (CAFs) as germline surrogates when blood is not available. Multiple bioinformatics QC assessments have been developed to measure the genomic fidelity in these PDX models using low-pass whole genome sequencing (LP-WGS) and in CAFs using whole exome sequencing (WES). Methods: LP-WGS was performed on 502 PDX samples from 38 models of rare cancer across passages 2 through 9 and WES was performed on 92 CAFs from 32 different histologies. In the QC workflow for estimating the genomic stability of passages within models, BBSplit was used for the assessment of human/mouse DNA content. CNVkit was utilized for copy number (CN) detection. The fraction of genome changed was calculated by comparing the copy numbers of each passage sample to the original patient sample. To evaluate purity of CAFs, three QC steps were constructed: a) plot of SNP variant allele frequency (ideogram); b) variant annotation using OncoKB (www.oncokb.org); c) percentage of genomic loss of heterozygosity (LOH), based on a set of ~800,000 heterozygous SNPs from a population-level genomic database (gnomAD) based on WES data. Results: PDX models showed genomic stability in CN profile when measured by LP-WGS. Human tumor DNA content remains stable ranging from 75-85% across different tiers of PDX passages from Donor +1 to Donor +6 and more. No models showed statistically significant evolution in CN profile, given the average 5 samples per model in each tier of passages. The QC workflow for CAFs generated five categories based on SNP ideograms, the presence/absence of oncogenic variants and LOH. Following observations were made: a) 72.5% CAFs were confirmed as matched diploid CAFs (category 1); b) 6.6% of CAFs were diploid and had &gt;= 1 germline oncogenic variant - classified as category 2. CAFs in category 1&2 were suitable as germline surrogates; c) 12% of CAFs (category 3) showed putative polyploidy on SNP ideograms with no oncogenic variants and suitable for somatic variant calling; d) 8.8% of CAFs (category 4) had polyploidy and oncogenic variants present; e) LOH high CAF (category 5) - we identified a CAF with 42% LOH, later confirmed to be a tumor cell line by immunohistochemistry (IHC). Other CAFs (n=91) showed little variance, ranging from 0.6%-1.7% LOH. Conclusions: We developed standard QC workflows to evaluate genomic stability of PDX models during passaging and qualify CAFs as germline surrogates for pre-clinical study. Citation Format: Ting-Chia Chang, Li Chen, Biswajit Das, Yvonne A. Evrard, Chris A. Karlovich, Tomas Vilimas, Alyssa Chapman, Nikitha Nair, Luis Romero, Anna J. Lee Fong, Amanda Peach, Brandie Fullmer, Lindsay Dutko, Kelly Benauer, Gloryvee Rivera, Erin Cantu, Shahanawaz Jiwani, Nastaran Neishaboori, Tomas Forbes, Corinne Camalier, Luke Stockwin, Michael Mullendore, Michelle A. Eugeni, Dianne Newton, Melinda G. Hollingshead, Mickey P. Williams, James H. Doroshow. Quality control workflows developed for the NCI Patient-Derived Models Repository using low pass whole genome sequencing and whole exome sequencing [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1913." @default.
• W4282965626 created "2022-06-17" @default.
• W4282965626 creator A5006623171 @default.
• W4282965626 creator A5009325188 @default.
• W4282965626 creator A5011216065 @default.
• W4282965626 creator A5013918494 @default.
• W4282965626 creator A5016211896 @default.
• W4282965626 creator A5019372914 @default.
• W4282965626 creator A5022166540 @default.
• W4282965626 creator A5029289035 @default.
• W4282965626 creator A5029895728 @default.
• W4282965626 creator A5037989560 @default.
• W4282965626 creator A5038318669 @default.
• W4282965626 creator A5038405039 @default.
• W4282965626 creator A5039374231 @default.
• W4282965626 creator A5040677714 @default.
• W4282965626 creator A5041200743 @default.
• W4282965626 creator A5044153234 @default.
• W4282965626 creator A5053025161 @default.
• W4282965626 creator A5054948261 @default.
• W4282965626 creator A5059471274 @default.
• W4282965626 creator A5064727510 @default.
• W4282965626 creator A5066106192 @default.
• W4282965626 creator A5070371862 @default.
• W4282965626 creator A5072749934 @default.
• W4282965626 creator A5080549130 @default.
• W4282965626 creator A5080778766 @default.
• W4282965626 creator A5080843003 @default.
• W4282965626 creator A5090807615 @default.
• W4282965626 date "2022-06-15" @default.
• W4282965626 modified "2023-09-27" @default.
• W4282965626 title "Abstract 1913: Quality control workflows developed for the NCI Patient-Derived Models Repository using low pass whole genome sequencing and whole exome sequencing" @default.
• W4282965626 doi "https://doi.org/10.1158/1538-7445.am2022-1913" @default.
• W4282965626 hasPublicationYear "2022" @default.
• W4282965626 type Work @default.
• W4282965626 citedByCount "0" @default.
• W4282965626 crossrefType "journal-article" @default.
• W4282965626 hasAuthorship W4282965626A5006623171 @default.
• W4282965626 hasAuthorship W4282965626A5009325188 @default.
• W4282965626 hasAuthorship W4282965626A5011216065 @default.
• W4282965626 hasAuthorship W4282965626A5013918494 @default.
• W4282965626 hasAuthorship W4282965626A5016211896 @default.
• W4282965626 hasAuthorship W4282965626A5019372914 @default.
• W4282965626 hasAuthorship W4282965626A5022166540 @default.
• W4282965626 hasAuthorship W4282965626A5029289035 @default.
• W4282965626 hasAuthorship W4282965626A5029895728 @default.
• W4282965626 hasAuthorship W4282965626A5037989560 @default.
• W4282965626 hasAuthorship W4282965626A5038318669 @default.
• W4282965626 hasAuthorship W4282965626A5038405039 @default.
• W4282965626 hasAuthorship W4282965626A5039374231 @default.
• W4282965626 hasAuthorship W4282965626A5040677714 @default.
• W4282965626 hasAuthorship W4282965626A5041200743 @default.
• W4282965626 hasAuthorship W4282965626A5044153234 @default.
• W4282965626 hasAuthorship W4282965626A5053025161 @default.
• W4282965626 hasAuthorship W4282965626A5054948261 @default.
• W4282965626 hasAuthorship W4282965626A5059471274 @default.
• W4282965626 hasAuthorship W4282965626A5064727510 @default.
• W4282965626 hasAuthorship W4282965626A5066106192 @default.
• W4282965626 hasAuthorship W4282965626A5070371862 @default.
• W4282965626 hasAuthorship W4282965626A5072749934 @default.
• W4282965626 hasAuthorship W4282965626A5080549130 @default.
• W4282965626 hasAuthorship W4282965626A5080778766 @default.
• W4282965626 hasAuthorship W4282965626A5080843003 @default.
• W4282965626 hasAuthorship W4282965626A5090807615 @default.
• W4282965626 hasConcept C104317684 @default.
• W4282965626 hasConcept C10590036 @default.
• W4282965626 hasConcept C141231307 @default.
• W4282965626 hasConcept C143589142 @default.
• W4282965626 hasConcept C162324750 @default.
• W4282965626 hasConcept C16671776 @default.
• W4282965626 hasConcept C176217482 @default.
• W4282965626 hasConcept C180754005 @default.
• W4282965626 hasConcept C197077220 @default.
• W4282965626 hasConcept C21547014 @default.
• W4282965626 hasConcept C24432333 @default.
• W4282965626 hasConcept C2779346075 @default.
• W4282965626 hasConcept C2908647359 @default.
• W4282965626 hasConcept C501734568 @default.
• W4282965626 hasConcept C54355233 @default.
• W4282965626 hasConcept C70721500 @default.
• W4282965626 hasConcept C71924100 @default.
• W4282965626 hasConcept C86803240 @default.
• W4282965626 hasConcept C99454951 @default.
• W4282965626 hasConceptScore W4282965626C104317684 @default.
• W4282965626 hasConceptScore W4282965626C10590036 @default.
• W4282965626 hasConceptScore W4282965626C141231307 @default.
• W4282965626 hasConceptScore W4282965626C143589142 @default.
• W4282965626 hasConceptScore W4282965626C162324750 @default.
• W4282965626 hasConceptScore W4282965626C16671776 @default.
• W4282965626 hasConceptScore W4282965626C176217482 @default.
• W4282965626 hasConceptScore W4282965626C180754005 @default.
• W4282965626 hasConceptScore W4282965626C197077220 @default.
• W4282965626 hasConceptScore W4282965626C21547014 @default.
• W4282965626 hasConceptScore W4282965626C24432333 @default.
• W4282965626 hasConceptScore W4282965626C2779346075 @default.
• W4282965626 hasConceptScore W4282965626C2908647359 @default.
• W4282965626 hasConceptScore W4282965626C501734568 @default.
• W4282965626 hasConceptScore W4282965626C54355233 @default.

• next